Impact of Everolimus on HIV Persistence Post Kidney (and Kidney/Pancreas) or Liver Transplant
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Everolimus (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms HIVTR-EVE
- 31 Oct 2017 Planned End Date changed from 1 Jun 2017 to 1 Jan 2018.
- 31 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jan 2018.
- 31 Oct 2017 Status changed from recruiting to active, no longer recruiting.